Literature DB >> 9092114

Angiogenesis in colorectal cancer.

T J Saclarides1.   

Abstract

Angiogenesis is a complicated multistep process involving the breakdown of the endothelial cell basement membrane, digestion of the extracellular matrix, proliferation and migration of endothelial cells toward the angiogenic stimulus, and formation of functioning capillaries. This neovascular network not only provides nutrients for an expanding tumor mass but also a means of dissemination to sites far removed from the primary tumor site. The entire process is mediated by cytokines or growth factors released either by the tumor cells themselves or by endogenous cells within the microenvironment surrounding the tumor. The literature has conclusively shown that those lesions with high angiogenesis scores or microvessel densities are associated with a higher risk of metastases, recurrence, and early patient death. This is especially so for colorectal cancer. Antiangiogenesis therapy holds promise for the future and, in the adjuvant setting, has many theoretical advantages over conventional cytotoxic chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9092114     DOI: 10.1016/s0039-6109(05)70543-0

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  7 in total

1.  The expression of non-mast histamine in tumor associated microvessels in human colorectal cancers.

Authors:  Jing Cui; Gang Xu; Jinzhong Liu; Zhigang Pang; Jon Florholmen; Guanglin Cui
Journal:  Pathol Oncol Res       Date:  2012-12-14       Impact factor: 3.201

2.  Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells.

Authors:  Dalila Darmoul; Valérie Gratio; Hélène Devaud; Thérèse Lehy; Marc Laburthe
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

3.  Integrated Mueller-matrix near-infrared imaging and point-wise spectroscopy improves colonic cancer detection.

Authors:  Jianfeng Wang; Wei Zheng; Kan Lin; Zhiwei Huang
Journal:  Biomed Opt Express       Date:  2016-03-03       Impact factor: 3.732

4.  Significance of angiogenic factors in liver metastatic tumors originating from colorectal cancers.

Authors:  A Nanashima; M Ito; I Sekine; S Naito; H Yamaguchi; T Nakagoe; H Ayabe
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

5.  Angiogenesis and dendritic cell density are not correlated with metachronous distant metastasis in curatively operated rectal cancer.

Authors:  K Günther; T Radkow; M A Reymond; R Pflüger; A Dimmler; W Hohenberger; T Papadopoulos
Journal:  Int J Colorectal Dis       Date:  2003-02-08       Impact factor: 2.571

6.  Bevacizumab plus infusional 5-fluorouracil, leucovorin and irinotecan for advanced colorectal cancer that progressed after oxaliplatin and irinotecan chemotherapy: a pilot study.

Authors:  Hyuk-Chan Kwon; Sung Yong Oh; Suee Lee; Sung-Hyun Kim; Hyo-Jin Kim
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

Review 7.  Relationship between hypoxia and response to antiangiogenic therapy in metastatic colorectal cancer.

Authors:  Paola Ulivi; Giorgia Marisi; Alessandro Passardi
Journal:  Oncotarget       Date:  2016-07-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.